WHP Global on a definitive agreement to form a new joint venture with Lands’ End Inc. (Nasdaq: LE), a provider of apparel, swimwear, outerwear, accessories, footwear, home products and uniforms.
Akero Therapeutics (Nasdaq: AKRO), a clinical-stage company developing treatments for patients with metabolic diseases, in its $5.2 billion sale to Novo Nordisk (NYSE: NVO).
3G Capital in connection with the $8 billion financing for its acquisition of Skechers (NYSE: SKX).
Scorpion Therapeutics in its $2.5 billion pending sale of the PI3Kα inhibitor program, a treatment for breast cancers in clinical trials, to Eli Lilly and Company (NYSE: LLY).
